Clinical Trial Update: Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pharmacodynamic parameters and tolerability of grass pollen subcutaneous immunotherapy in patients with allergic rhinitis and co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis
• Asthma

Drugs mentioned

• Grass pollen subcutaneous immunotherapy

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinitis, Conjunctivitis | Phase 2 | Status: COMPLETED